A detailed history of First Foundation Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, First Foundation Advisors holds 2,618 shares of LLY stock, worth $2.08 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,618
Previous 2,785 6.0%
Holding current value
$2.08 Million
Previous $2.52 Million 8.01%
% of portfolio
0.09%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $128,947 - $160,323
-167 Reduced 6.0%
2,618 $2.32 Million
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $41,317 - $51,815
57 Added 2.09%
2,785 $2.52 Million
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $27,833 - $37,237
-47 Reduced 1.69%
2,728 $2.12 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $966,349 - $1.14 Million
-1,840 Reduced 39.87%
2,775 $1.62 Million
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $113,891 - $157,016
262 Added 6.02%
4,615 $2.48 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $274,278 - $366,742
782 Added 21.9%
4,353 $2.04 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $64,611 - $75,882
-208 Reduced 5.5%
3,571 $1.23 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $76,207 - $88,796
-237 Reduced 5.9%
3,779 $1.38 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $24,014 - $27,367
81 Added 2.06%
4,016 $1.3 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $16,723 - $19,636
-60 Reduced 1.5%
3,935 $1.28 Million
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $76,978 - $95,664
328 Added 8.94%
3,995 $1.14 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $180,779 - $224,348
804 Added 28.08%
3,667 $1.01 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $160,881 - $197,987
726 Added 33.97%
2,863 $662,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $7,763 - $10,042
-43 Reduced 1.97%
2,137 $491,000
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $74,272 - $96,149
452 Added 26.16%
2,180 $407,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $20,873 - $27,620
160 Added 10.2%
1,728 $292,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $7,457 - $8,625
-51 Reduced 3.15%
1,568 $232,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $220,863 - $265,807
1,619 New
1,619 $266,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $319,302 - $347,318
-2,990 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $53,068 - $61,944
-479 Reduced 13.81%
2,990 $331,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $43,410 - $51,097
390 Added 12.67%
3,469 $450,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $6,777 - $7,592
64 Added 2.12%
3,079 $356,000
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $24,470 - $30,583
-285 Reduced 8.64%
3,015 $324,000
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $41,635 - $47,784
-550 Reduced 14.29%
3,300 $282,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $109,830 - $129,647
-1,480 Reduced 27.77%
3,850 $298,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $115,913 - $128,652
-1,504 Reduced 22.01%
5,330 $456,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,834
6,834 $562,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.